US FDA approves Spark’s gene therapy Luxturna for rare form of vision loss
Luxturna FDA approval : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics has secured the approval from the US
Continue readingCoverage of Global Pharma Industry News
Luxturna FDA approval : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics has secured the approval from the US
Continue readingMylan has secured the US FDA approval for Estradiol Vaginal Cream USP, 0.01%, the generic version of Allergan’s vaginal estrogen
Continue readingEli Lilly and Company, which is better known as Lilly, says that a late-stage trial of Cyramza (ramucirumab) for the
Continue readingRepatha FDA approval news : Repatha (evolocumab), the Amgen cholesterol drug has bagged the approval from the US Food and
Continue reading